Health Condition 1: K51- Ulcerative colitis Health Condition 2: null- Ulcerative Colitis in Remission
Conditions
Interventions
Intervention1: Fecal Microbiota Transplant: Patients suffering from Ulcerative Colitis who are in clinical remission will be enrolled after obtaining informed consent. Donor faeces (80 gm) will be dil
Sponsors
Arshdeep Singh
Eligibility
Inclusion criteria
Inclusion criteria: 1. Confirmed Ulcerative Colitis patients who are in clinical remission (defined as complete resolution of symptoms) for a minimum duration of 6 months. 2. Patients must be on stable medication regimen for at least 6 months prior to enrollment. 3. Able to give informed consent and/or assent as appropriate
Exclusion criteria
Exclusion criteria: 1. Patients with active disease 2. Patients having toxic megacolon 3. Treatment naïve patients 4. Pregnant and lactating ladies 5. Prior colectomy 6. Positive stool test for any of the following: Clostridium difficile, Salmonella, Shigella, Yersinia, Campylobacter, E. coli by standard stool culture. 7. Regular probiotic supplement use within prior 4 weeks to enrollment 8. Severe immunodeficiency, inherited or acquired (e.g. HIV, chemotherapy, or radiation therapy) 9. Patients unwilling or unable to give consent or participate in all study requirements
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Comparison of clinical response in two groupsTimepoint: One Year | — |
Secondary
| Measure | Time frame |
|---|---|
| Comparison of Endoscopic activity of Ulcerative ColitisTimepoint: 1 year | — |
Countries
India
Contacts
Public ContactDr Arshdeep Singh
Dayanand Medical College and Hospital
Outcome results
None listed